Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 1, 2016
Pharmacy Choice - News - U.S. Pharmaceutical Industry - July 1, 2016

Pharmacy News

 U.S. Pharmaceutical Industry
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

7/1/16 - "Heat-Stable Dry Powder Pharmaceutical Compositions and Methods" in Patent Application Approval Process (USPTO 20160158156)
By a News Reporter-Staff News Editor at Drug Week A patent application by the inventors Fabio, Karine; Guarneri, Joseph J.; Curley, Kieran; Grant, Marshall L.; Leone-Bay, Andrea, filed on July 18, 2014, was made available online on June 16, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent
7/1/16 - AbbVie's HUMIRA (adalimumab) Receives U.S. Food and Drug Administration Approval to Treat Adults with Non-Infectious Intermediate, Posterior and Panuveitis
AbbVie, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration has approved HUMIRA for the treatment of non-infectious intermediate, posterior and panuveitis. HUMIRA is now the first and only FDA- approved non-corticosteroid therapy available for adults with non infectious intermediate, posterior and.
7/1/16 - Allergan Reaches Out To Family Caregivers Of People With Alzheimer's Disease With New PSA, Website
By a News Reporter-Staff News Editor at Health& Medicine Week Allergan plc, a leading global pharmaceutical company, announced its support of two new caregiver initiatives, a public service announcement and a caregiver resource website. Allergan partnered with the Alzheimer's Foundation of America and Kim Campbell wife of country music legend,
7/1/16 - Allergan to Present New Data from its Anti-Infectives Portfolio at ASM Microbe 2016 in Boston
By a News Reporter-Staff News Editor at Drug Week Allergan plc, a leading global pharmaceutical company committed to the research and development of new treatments for infectious diseases, announced that new data from its anti-infectives portfolio will be featured in 14 presentations at the upcoming ASM Microbe, June 16-20, 2016, in Boston an i
7/1/16 - BioLineRx to Present at the JMP Securities Life Sciences Conference in New York
By a News Reporter-Staff News Editor at Drug Week BioLineRx Ltd., a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced that its Chief Executive Officer, Kinneret Savitsky, Ph.D., and its Chief Financial and Operating Officer, Philip Serlin, will be presenting
7/1/16 - bioMerieux Receives FDA Clearance for Expanded Use of VIDAS B.R.A.H.M.S PCT? Test for Managing Sepsis Patients with Elevated Risk of Mortality
MARCY L ?TOILE, France Regulatory News:. bioMrieux, a world leader in the field of in vitro diagnostics, today announced that it has received 510 clearance from the U.S. Food and Drug Administration to expand the use of the VIDAS B? R? A? H? M? S PCT? assay using the change in PCT levels over time to aid in the management o
7/1/16 - Data from CSIR Provide New Insights into Toxicology and Pharmacology (A three-tier QSAR modeling strategy for estimating eye irritation potential of...
By a News Reporter-Staff News Editor at Drug Week Investigators publish new report on Drugs and Therapies. According to news reporting out of Uttar Pradesh, India, by NewsRx editors, research stated, "Experimental determination of the eye irritation potential of chemicals is not only tedious, time and resource intensive, it involves cruelty to te
7/1/16 - Early Clinical Trials With Live Biotherapeutic Products: Chemistry, Manufacturing, and Control Information; Guidance for Industry; Availability
SUMMARY: The Food and Drug Administration is announcing the availability of a document entitled "Early Clinical Trials With Live Biotherapeutic Products: Chemistry, Manufacturing, and Control Information; Guidance for Industry." The guidance document provides investigational new drug application sponsors with recommendations regarding IND...
7/1/16 - Espero Pharmaceuticals Receives FDA Approval for GONITRO? Nitroglycerin Sublingual Powder
By a News Reporter-Staff News Editor at Drug Week Espero Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, announced that the U.S. Food and Drug Administration has approved GONITRO? sublingual powder for acute relief of an attack or prophylaxis of angina pectoris due to coronary artery disease. "The FDA approval of GONI
7/1/16 - Former Bayer and Pharmacia Senior Executive Rolf A. Classon Joins the Sequana Medical AG Board as Chairman
In addition to Sequana Medical, Mr. Classon currently serves on the Boards of NYSE and Zurich Stock Exchange- listed companies, Catalent Pharma Solutions, Fresenius Medical Care, Hill-Rom Holdings, Inc. and Tecan Group Ltd., and recently stepped down from the Boards of Aerocrine AB and Auxilium Pharmaceuticals, Inc. after successful sale of the com
7/1/16 - Help Pfizer Change The Future Of Healthy Aging
By a News Reporter-Staff News Editor at Drug Week Pfizer Inc. is challenging people across the United States to develop the next big idea in healthy aging through a unique partnership with crowdfunding platform Indiegogo. The best idea will receive U.S. $50,000 in funding and an opportunity to meet with a team of Pfizer experts to help bring it f
7/1/16 - Lannett Receives FDA Approval For Neomycin Sulfate Tablets USP, 500 mg
By a News Reporter-Staff News Editor at Drug Week Lannett Company, Inc. announced that it has received approval from the U.S. Food and Drug Administration of its Abbreviated New Drug Application for Neomycin Sulfate Tablets USP, 500 mg, the therapeutic equivalent to the reference listed drug, Neomycin Sulfate Tablets USP, 500 mg, of Teva Pharmace
7/1/16 - Mallinckrodt Submits Investigational New Drug Application for Synacthen Depot
By a News Reporter-Staff News Editor at Drug Week Mallinckrodt plc, a leading global specialty biopharmaceutical company, announced it has submitted an Investigational New Drug application for Synacthen Depot to the U.S. Food and Drug Administration. Mallinckrodt has invested substantially in the research program, including completing the...
7/1/16 - Nephron Pharmaceuticals Corporation Launches Generic Budesonide Inhalation Suspension
By a News Reporter-Staff News Editor at Drug Week Nephron Pharmaceuticals Corporation launched generic Budesonide Inhalation Suspension yesterday. Nephron has licensed the Abbreviated New Drug Application from Apotex, Inc. Budesonide Inhalation Suspension is the generic version of Pulmicort Respules manufactured by AstraZeneca LP.
7/1/16 - OPKO Health to Host Analyst & Investor Day in New York City on June 15
By a News Reporter-Staff News Editor at Drug Week OPKO Health, Inc. announces that it will host an Analyst& Investor Day on Wednesday, June 15, 2016 beginning at 4:30 p.m. local time in New York City. Phillip Frost, M.D., Chairman and Chief Executive Officer of OPKO Health, will host the event along with other key members of OPKO Health senior ma
7/1/16 - Patent Issued for 9-Aminomethyl Substituted Minocycline Compounds (USPTO 9365500)
By a News Reporter-Staff News Editor at Drug Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Nelson, Mark L.; Frechette, Roger; Ismail, Mohamed Y.; Honeyman, Laura; Bowser, Todd; Bhatia, Beena, filed on June 27, 2014, was published online on June 14, 2016. The patent's assignee for patent number 9365500 is
7/1/16 - Patent Issued for Alternating Sympathomimetic Therapy for the Treatment of Respiratory Ailments (USPTO 9364451)
By a News Reporter-Staff News Editor at Drug Week A patent by the inventors Dixit, Suresh; Menendez, Juan Carlos; Brown, Ralph, filed on January 7, 2014, was published online on June 14, 2016, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 9364451 is assigned to Sovereign Pharmaceuticals
7/1/16 - Patent Issued for Coumarin Derivative (USPTO 9365533)
By a News Reporter-Staff News Editor at Drug Week A patent by the inventors Naiki, Mitsuru; Okada, Tomoyuki; Sawada, Kazuyoshi; Ogino, Takashi, filed on September 20, 2013, was published online on June 14, 2016, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 9365533 is assigned to NIPPON
7/1/16 - Patent Issued for Mounting Arrangement and Coupling Assembly for a Drug-Delivery Device (USPTO 9364613)
By a News Reporter-Staff News Editor at Drug Week A patent by the inventor Harms, Michael, filed on March 31, 2010, was published online on June 14, 2016, according to news reporting originating from Alexandria, Virginia, by NewsRx correspondents. Patent number 9364613 is assigned to SANOFI-AVENTIS DEUTSCHLAND GMBH. The following quote was obtain
7/1/16 - Patent Issued for Pharmaceutical Composition for Preventing Or Treating Hepatic Fibrosis and Cirrhosis Containing Ramalin (USPTO 9364452)
By a News Reporter-Staff News Editor at Drug Week From Alexandria, Virginia, NewsRx journalists report that a patent by the inventors Yim, Joung Han; Kim, Il Chan; Han, Se Jong; Lee, Hyoung Seok; Bhattarai, Hari Datta; Yang, Su-Geun; Hang, Lee Don, filed on February 29, 2012, was published online on June 14, 2016. The patent's assignee for patent
7/1/16 - Patent Issued for Pharmaceutical Compositions Containing Functionalized Triblock Copolymers (USPTO 9364544)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Alexandria, Virginia, by NewsRx journalists, a patent by the inventors Pierre, Sebastien Jerome; De Leeuw, Mike, filed on September 14, 2015, was published online on June 14, 2016. The assignee for this patent, patent number 9364544, is Ingell Technolog
7/1/16 - Patent Issued for Process for Preparing a Crystalline Form of Halobetasol Propionate (USPTO 9365609)
By a News Reporter-Staff News Editor at Drug Week TARO PHARMACEUTICALS NORTH AMERICA, INC. has been issued patent number 9365609, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Gutman, Daniella; Chernyak, Shimon. This patent was filed on January 7, 2013 and was published online o
7/1/16 - Patent Issued for Regeneration of Chromatographic Stationary Phases (USPTO 9364772)
By a News Reporter-Staff News Editor at Drug Week Novo Nordisk A/S has been issued patent number 9364772, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors. The patent's inventors are Larsen, Per; Schou, Ole; Rasmussen, Eigil Schroder. This patent was filed on April 7, 2008 and was published online on June 14,
7/1/16 - Researchers Submit Patent Application, "Inhalable Pharmaceutical Compositions and the Inhaler Devices Containing Them", for Approval (USPTO...
Researchers Submit Patent Application, "Inhalable Pharmaceutical Compositions and the Inhaler Devices Containing Them", for Approval. By a News Reporter-Staff News Editor at Drug Week From Washington, D.C., NewsRx journalists report that a patent application by the inventors Kamlag, Yorick; Keil, Mathias, filed on April 28, 2014, was made availab
7/1/16 - Teva Announces Favorable Court Ruling in TREANDA bendamustine hydrochloride Patent Infringement Litigation
By a News Reporter-Staff News Editor at Drug Week Teva Pharmaceutical Industries Ltd. announced that the United States District Court for the District of Delaware has ruled in favor of Teva in the Company's patent infringement lawsuit against Hetero USA, Inc., InnoPharma Inc., Hospira Inc., Sagent Pharmaceuticals Inc., and Accord Healthcare Inc.,
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415